News
Important Only
BRIEF-Halcones Precious Provides Update On Option Agreement To Acquire The Polaris Project
Dec 31 (Reuters) - Halcones Precious Metals Corp HPM.V:HALCONES PRECIOUS PROVIDES UPDATE ON OPTION AGREEMENT TO ACQUIRE THE POLARIS PROJECTHALCONES PRECIOUS METALS CORP - ENTERS NEW AGREEMENT WITH AUSTRAL EXPLORACIONESHALCONES PRECIOUS METALS CORP - NEW AGREEMENT SUPERSEDES ORIGINAL AGREEMENT DATED ...Reuters
Tue, Dec 31
UPDATE 2-Merck wins UK approval for lung disease drug acquired in $11 bln deal
Adds approval details in paragraphs 3 and 5, background on other approvals and pricing in paragraphs 2 and 9Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's MRK.N therapy to treat a rare lung condition, marking another win for the dr...Reuters
Tue, Dec 31
U.S. RESEARCH ROUNDUP-Axsome Therapeutics, Ducommun, Vacasa
Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Axsome Therapeutics, Ducommun and Vacasa on Tuesday. HIGHLIGHTS* Axsome Therapeutics Inc AXSM.O: Needham raises target price to $133 from $130* Comstock Resources In...Reuters
Tue, Dec 31
Yemen will continue to defend itself, say Houthis after US strikes
CAIRO, Dec 31 (Reuters) - The chief negotiator for Yemen's Houthi movement said on Tuesday that the country would continue to defend itself after several U.S. strikes targeted facilities in the capital Sanaa. (Reporting by Enas Alashray and Nayera AbdallahEditing by Gareth Jones)Reuters
Tue, Dec 31
Tennis-Olympic medallist Dabrowski played season after cancer surgery
Dec 31 (Reuters) - Canada's former U.S. Open doubles champion and Paris Olympic bronze medallist Gabriela Dabrowski said on Tuesday she underwent breast cancer surgery earlier this year.The 32-year-old was diagnosed in April.Following two surgeries and a three-month WTA Tour break, the former Austra...Reuters
Tue, Dec 31
BRIEF-Veru Announces The Sale Of The FC2 Female Condom Business
Dec 31 (Reuters) - Veru Inc VERU.O:VERU ANNOUNCES THE SALE OF THE FC2 FEMALE CONDOM® (INTERNAL CONDOM) BUSINESSVERU INC - SELLS FC2 FEMALE CONDOM BUSINESS FOR $18 MILLIONVERU INC - TO REDUCE HEADCOUNT BY APPROXIMATELY 90% AFTER FC2 SALEVERU INC - EXPECTS $12.5 MILLION PROCEEDS AFTER DEDUCTIONS FROM ...Reuters
Tue, Dec 31
BRIEF-Chart Industries Bechtel And Woodside Place Woodside Louisiana LNG Phase 1 Order To Chart Industries
Dec 31 (Reuters) - Chart Industries Inc GTLS.N:CHART INDUSTRIES: BECHTEL AND WOODSIDE PLACE WOODSIDE LOUISIANA LNG PHASE 1 ORDER TO CHART INDUSTRIESCHART INDUSTRIES: UNDER ORDER, TO SUPPORT PHASE 1 OF LOUISIANA LNG BY PROVIDING 2 LNG PLANTS COMPRISING 16 COLD BOXES FOR 11 MTPA PRODUCTIONSource text:...Reuters
Tue, Dec 31
BRIEF-India Competition Regulator Approves Acquisition Of All Outstanding Shares Of Kellanova By Mars
Dec 31 (Reuters) - Kellanova K.N:INDIA COMPETITION REGULATOR APPROVES ACQUISITION OF ALL OUTSTANDING SHARES OF KELLANOVA BY MARSSource text: [ID:]Further company coverage: K.N ((Reuters.Briefs@thomsonreuters.com;;))Reuters
Tue, Dec 31
BRIEF-BTQ Technologies Announces Strategic Collaboration With South Korean Quantum Organizations
Dec 31 (Reuters) - BTQ Technologies Corp BTQ.NLB:BTQ TECHNOLOGIES ANNOUNCES STRATEGIC COLLABORATION WITH SOUTH KOREAN QUANTUM ORGANIZATIONSSource text: ID:nCNWl6tqlaFurther company coverage: BTQ.NLB ((reuters.briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
BRIEF-Softchoice Corp To Be Acquired By World Wide Technology For C$24.50 Per Share
Dec 31 (Reuters) - Softchoice Corp SFTC.TO:SOFTCHOICE CORPORATION AND WORLD WIDE TECHNOLOGY ENTER INTO DEFINITIVE AGREEMENT FOR SOFTCHOICE TO BE ACQUIRED BY WORLD WIDE TECHNOLOGY AT A PRICE OF C$24.50 PER SHARESOFTCHOICE CORP - TO BE ACQUIRED BY WORLD WIDE TECHNOLOGY FOR C$24.50 PER SHARESOFTCHOICE ...Reuters
Tue, Dec 31
BRIEF-Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Dec 31 (Reuters) - Abeona Therapeutics Inc ABEO.O:ABEONA THERAPEUTICS® ANNOUNCES NEW EMPLOYEE INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)Source text: ID:nGNX5sLWFcFurther company coverage: ABEO.O ((reuters.briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
BRIEF-Definitive Proxy Statement Filed In Connection With Oneok's Pending Acquisition Of The Remaining Publicly Held Common Units Of Enlink Midstream
Dec 31 (Reuters) - EnLink Midstream LLC ENLC.N:DEFINITIVE PROXY STATEMENT FILED IN CONNECTION WITH ONEOK'S PENDING ACQUISITION OF THE REMAINING PUBLICLY HELD COMMON UNITS OF ENLINK MIDSTREAMSource text: ID:nPn8JlyxpaFurther company coverage: ENLC.N ((reuters.briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
BRIEF-Bunker Hill Announces Closing Of Fifth Tranche Of The Silver Loan Facility
Dec 31 (Reuters) - Bunker Hill Mining Corp BNKR.V:BUNKER HILL ANNOUNCES CLOSING OF FIFTH TRANCHE OF THE SILVER LOAN FACILITYSource text: ID:nGNX7x6gsLFurther company coverage: BNKR.V ((reuters.briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
UPDATE 1-UK approves Merck's therapy for rare lung condition
Adds drug details in paragraphs 2,3 and 4Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's MRK.N therapy to treat a rare lung condition called pulmonary arterial hypertension.The therapy, sotatercept, received approval in the U...Reuters
Tue, Dec 31
INSIGHT-Inside luxury goods' broken audit system
By Elisa Anzolin, Emilio Parodi and Silvia Ognibene MILAN, Dec 31 (Reuters) - LVMH-owned Dior's production arm in Italy, Manufactures Dior, relied on formal inspections to assess working and safety standards inside its supply chain last year. In some cases, such certifications missed glaring prob...Reuters
Tue, Dec 31
UK approves Merck's therapy for rare lung condition
Dec 31 (Reuters) - UK's Medicines and Healthcare products Regulatory Agency (MHRA) said on Tuesday it had approved Merck's MRK.N therapy, sotatercept, to treat a rare lung condition. (Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D'Silva) ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. ...Reuters
Tue, Dec 31
BRIEF-UK's MHRA Approves Sotatercept To Treat Adults With Pulmonary Arterial Hypertension
Dec 31 (Reuters) - UK's MHRA: UK'S MHRA: SOTATERCEPT APPROVED TO TREAT ADULT PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION (PAH)Further company coverage: MRK.N ((Reuters.Briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
DIARY-Political and General News Events from December 31
Dec 31 (Reuters) - For other diaries, please see:Political and General News POL/DIARYTop Economic Events M/DIARYEmerging Markets Economic Events EMRG/DIARYGovernment Debt Auctions D/DIARYU.S. Federal Reserve FED/DIARYToday in Washington WASH/DIARY ---------...Reuters
Tue, Dec 31
BRIEF-Galera Therapeutics Completes Acquisition Of Nova Pharmaceuticals
Dec 31 (Reuters) - Galera Therapeutics Inc GRTX.PK:GALERA THERAPEUTICS COMPLETES ACQUISITION OF NOVA PHARMACEUTICALSSource text: ID:nGNXbVgVJ0Further company coverage: GRTX.PK ((reuters.briefs@thomsonreuters.com;))Reuters
Tue, Dec 31
